Literature DB >> 33708479

Tricuspid annular dimensions in patients with severe mitral regurgitation without severe tricuspid regurgitation.

Sohum Kapadia1, Amar Krishnaswamy1, Habib Layoun1, Brian P Griffin1, Per Wierup2, Paul Schoenhagen3, Serge C Harb1.   

Abstract

BACKGROUND: Concomitant TV repair during mitral valve (MV) surgery based on tricuspid valve annulus (TVA) dilation, rather than the degree of tricuspid regurgitation (TR), is beneficial and supported by the valve guidelines. We sought to determine TVA geometry and dimensions in controls and assess the changes that occur in patients with severe primary (PMR) and secondary (SMR) mitral regurgitation without TR.
METHODS: We analyzed cardiac computed tomographic angiography (CCTA) of 125 consecutive subjects: 50 controls with normal coronary CCTA and no valvular dysfunction, 50 PMR patients referred for robotic repair, and 25 SMR patients referred for transcatheter therapy. Patients with >2+ TR on echocardiography were excluded. Annular measurements were performed using dedicated software and compared. Correlations and determinants of TVA dimensions were analyzed.
RESULTS: Patients with SMR were older and had significantly more comorbidities. In controls, the TVA was larger and more planar and eccentric compared to the MV annulus (all P<0.01). Dimensions of both annuli correlated significantly (r≥0.5; P<0.001 for all dimensions) in controls and patients with severe MR. In both PMR and SMR, the TVA enlarged in all dimensions (P<0.01) with a trend towards becoming more circular. On multivariable regression, the MV annular area was the primary determinant of the TVA area (adjusted β=0.430, P<0.001).
CONCLUSIONS: Substantial changes in TVA dimensions are encountered in patients with severe MR even in the absence of severe TR such that TVA and MVA dimensions remain correlated. Close attention to the TVA in patients with severe MR is warranted. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Tricuspid annulus; mitral annulus; severe mitral regurgitation

Year:  2021        PMID: 33708479      PMCID: PMC7944191          DOI: 10.21037/cdt-20-903

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  37 in total

1.  Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery.

Authors:  Umberto Benedetto; Giovanni Melina; Emiliano Angeloni; Simone Refice; Antonino Roscitano; Cosimo Comito; Riccardo Sinatra
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01-11       Impact factor: 5.209

2.  Geometric changes after tricuspid annuloplasty and predictors of residual tricuspid regurgitation: a real-time three-dimensional echocardiography study.

Authors:  Sun-Yang Min; Jong-Min Song; Jeong-Hoon Kim; Min-Kyong Jang; Yun-Jeong Kim; Haeguen Song; Dae-Hee Kim; Jae Won Lee; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Eur Heart J       Date:  2010-07-02       Impact factor: 29.983

3.  Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.

Authors:  Georg Nickenig; Marcel Weber; Philipp Lurz; Ralph Stephan von Bardeleben; Marta Sitges; Paul Sorajja; Jörg Hausleiter; Paolo Denti; Jean-Noël Trochu; Michael Näbauer; Abdellaziz Dahou; Rebecca T Hahn
Journal:  Lancet       Date:  2019-11-07       Impact factor: 79.321

4.  Three-dimensional dynamic assessment of tricuspid and mitral annuli using cardiovascular magnetic resonance.

Authors:  Francesco Maffessanti; Paola Gripari; Gianluca Pontone; Daniele Andreini; Erika Bertella; Saima Mushtaq; Gloria Tamborini; Laura Fusini; Mauro Pepi; Enrico G Caiani
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-01-22       Impact factor: 6.875

Review 5.  Mitral Valve Imaging with CT: Relationship with Transcatheter Mitral Valve Interventions.

Authors:  Jonathan R Weir-McCall; Philipp Blanke; Christopher Naoum; Victoria Delgado; Jeroen J Bax; Jonathon Leipsic
Journal:  Radiology       Date:  2018-07-31       Impact factor: 11.105

6.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

7.  Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients.

Authors:  A Sagie; E Schwammenthal; L R Padial; J A Vazquez de Prada; A E Weyman; R A Levine
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

8.  Assessment of mitral valve adaptation with gated cardiac computed tomography: validation with three-dimensional echocardiography and mechanistic insight to functional mitral regurgitation.

Authors:  Jonathan Beaudoin; Wai-Ee Thai; Bryan Wai; Mark D Handschumacher; Robert A Levine; Quynh A Truong
Journal:  Circ Cardiovasc Imaging       Date:  2013-07-19       Impact factor: 7.792

9.  Quantitative analysis of mitral annular geometry and function in healthy volunteers using transthoracic three-dimensional echocardiography.

Authors:  Sorina Mihăilă; Denisa Muraru; Eleonora Piasentini; Marcelo Haertel Miglioranza; Diletta Peluso; Umberto Cucchini; Sabino Iliceto; Dragoş Vinereanu; Luigi P Badano
Journal:  J Am Soc Echocardiogr       Date:  2014-06-02       Impact factor: 5.251

10.  The relationship of mitral annular shape to the diagnosis of mitral valve prolapse.

Authors:  R A Levine; M O Triulzi; P Harrigan; A E Weyman
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

View more
  1 in total

Review 1.  Roles of Cardiac Computed Tomography in Guiding Transcatheter Tricuspid Valve Interventions.

Authors:  Habib Layoun; Paul Schoenhagen; Tom Kai Ming Wang; Rishi Puri; Samir R Kapadia; Serge C Harb
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.